Ignite Creation Date:
2024-05-06 @ 8:14 PM
Last Modification Date:
2024-10-26 @ 3:23 PM
Study NCT ID:
NCT06304441
Status:
RECRUITING
Last Update Posted:
2024-03-12
First Post:
2024-03-05
Brief Title:
Intra-pemetrexed Plus Third-generation Small Molecule TKI Drugs eg Osimertinib Versus Third-generation Small Molecule TKI Drugs Alone for Leptomeningeal Metastasis From Epidermal Growth Factor Receptor Mutation-Positive Non-Small-cell Lung Cancer
Sponsor:
Guangzhou Medical University
Organization:
Guangzhou Medical University
Organization Data
Organization:
Guangzhou Medical University
Class:
OTHER
Study ID:
IPVO
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Guangzhou Medical University
Lead Sponsor Class:
OTHER
Responsible Party:
Zhenyu Pan
Responsible Party Title:
Professor
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Guangzhou Medical University
Old Name:
None
Old Organization:
None